South Korea Laboratory Developed Tests Market Size & Outlook

The laboratory developed tests market in South Korea is expected to reach a projected revenue of US$ 157.6 million by 2030. A compound annual growth rate of 5.5% is expected of South Korea laboratory developed tests market from 2024 to 2030.

Revenue, 2023 (US$M)
$108.4
Forecast, 2030 (US$M)
$157.6
CAGR, 2024 - 2030
5.5%
Report Coverage
South Korea

South Korea laboratory developed tests market, 2018-2030 (US$M)

South

South Korea laboratory developed tests market highlights

  • The South Korea laboratory developed tests market generated a revenue of USD 108.4 million in 2023 and is expected to reach USD 157.6 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 5.5% from 2024 to 2030.
  • In terms of segment, molecular diagnostics was the largest revenue generating technology in 2023.
  • Immunoassays is the most lucrative technology segment registering the fastest growth during the forecast period.


Laboratory developed tests market data book summary

Market revenue in 2023USD 108.4 million
Market revenue in 2030USD 157.6 million
Growth rate5.5% (CAGR from 2023 to 2030)
Largest segmentMolecular diagnostics
Fastest growing segmentImmunoassays
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationImmunoassays, Hematology and Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Flow Cytometry, Mass Spectroscopy
Key market players worldwideQuest Diagnostics Inc, 23andMe Holding Co Class A, Abbott Laboratories, Guardant Health Inc, NeoGenomics, Siemens Healthineers AG ADR, Qiagen NV, Illumina Inc, Roche Holding AG ADR


Other key industry trends

  • In terms of revenue, South Korea accounted for 0.9% of the global laboratory developed tests market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China laboratory developed tests market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,142.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Laboratory Developed Tests Market Scope

Laboratory developed tests market segmentation & scope
Immunoassays
Hematology and Coagulation
Molecular Diagnostics
Microbiology
Clinical Chemistry
Histology/Cytology
Flow Cytometry
Mass Spectroscopy
Others
Genetic Disorders/Inherited Disease
Infectious & Parasitic Diseases
Immunology
Endocrine
Nutritional & Metabolic Disease
Cardiology
Mental/Behavioral Disorder
Pediatrics-specific Testing
Hematology/General Blood Testing
Bodily Fluid Analysis
Toxicology
Other Diseases
Companion Diagnostics
Genomics Sequencing & Other

Laboratory Developed Tests Market Companies

Name Profile # Employees HQ Website

South Korea laboratory developed tests market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to laboratory developed tests market will help companies and investors design strategic landscapes.


Molecular diagnostics was the largest segment with a revenue share of 23.8% in 2023. Horizon Databook has segmented the South Korea laboratory developed tests market based on immunoassays, hematology and coagulation, molecular diagnostics, microbiology, clinical chemistry, histology/cytology, flow cytometry, mass spectroscopy covering the revenue growth of each sub-segment from 2018 to 2030.


Cancer research has become a national priority for the Korean government. It supports several universities, institutions, and researchers to facilitate cancer research activities, which is anticipated to create significant demand for LDTs in the coming years for early and rapid diagnosis.


Furthermore, increasing R&D investments by key companies in South Korea are expected to create a lucrative environment for market growth. For instance, in October 2022, AstraZeneca announced that it will spend USD 630.0 million on R&D in South Korea over the next 5 years to improve access to healthcare.

Reasons to subscribe to South Korea laboratory developed tests market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea laboratory developed tests market databook

  • Our clientele includes a mix of laboratory developed tests market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea laboratory developed tests market , including forecasts for subscribers. This country databook contains high-level insights into South Korea laboratory developed tests market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea laboratory developed tests market size, by technology, 2018-2030 (US$M)

South Korea Laboratory Developed Tests Market Outlook Share, 2023 & 2030 (US$M)

South Korea laboratory developed tests market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more